Retinal microvascular dysfunction in hypercholesterolemia.
Nägele MPCardiology, University Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland.
Barthelmes JCardiology, University Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland.
Ludovici VCardiology, University Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland; Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila, Italy.
Cantatore SCardiology, University Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland.
Frank MCardiology, University Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland.
Ruschitzka FCardiology, University Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland.
Flammer AJCardiology, University Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland.
Sudano ICardiology, University Heart Center Zurich, University Hospital Zurich, Zurich, Switzerland. Electronic address: isabella.sudano@usz.ch.
English
BACKGROUND Hypercholesterolemia is one of the most important contributors to atherosclerosis. Whether hypercholesterolemia also affects the retinal microcirculation is unclear.
OBJECTIVE The goal of our study was to assess the association of cholesterol levels with retinal microvascular function using dynamic and static retinal vessel analysis (RVA) in a primary prevention setting.
METHODS This cross-sectional, observational study prospectively recruited 67 patients with hypercholesterolemia without known cardiovascular disease (mean age 64.4 ± 10.4 years; 45% female) and 78 healthy controls (mean age 61.8 ± 11.2 years; 45% female). The primary end point of the study was flicker-induced dilatation of retinal arterioles (FIDart) with secondary exploratory outcomes including venular FID (FIDven), arteriovenous ratio, flow-mediated dilatation and arterial stiffness as measured with augmentation index and pulse wave velocity. Multiple regression analysis was performed to study the association of cholesterol levels with retinal microvascular function.
RESULTS FIDart was significantly impaired in patients with hypercholesterolemia compared with healthy controls (mean FIDart 2.1 ± 1.8 vs 3.1 ± 1.8%, P = .001). This association remained when analysis was restricted to dyslipidemic patients without coexisting hypertension or lipid-lowering therapy. No significant differences remained for FIDven, flow-mediated dilatation, arteriovenous ratio, or arterial stiffness between the groups. Low-density lipoprotein, but not high-density lipoprotein, cholesterol was a significant negative predictor of FIDart in multiple regression analysis.
CONCLUSION Hypercholesterolemia is associated with significant retinal microvascular dysfunction as evidenced by a reduction in flicker-induced dilatation of retinal arterioles. Dynamic RVA may be a promising method for the study of retinal microvascular dysfunction in populations at elevated cardiovascular risk.